Point-of-Care Analyzer Kit
Binaxnow 22 Tests CLIA Waived
Alere LFR124

Point-of-Care Analyzer Kit<br>  Binaxnow 22 Tests CLIA Waived <br> Alere LFR124
Point-of-Care Analyzer Kit
Binaxnow 22 Tests CLIA Waived
Alere LFR124
Item# Alere-LFR124
Regular price: $400.00
Sale price: $3,726.99

Product Description

Point-of-Care Analyzer Kit<br>  Binaxnow 22 Tests CLIA Waived <br> Alere LFR124
Point-of-Care Analyzer Kit
Binaxnow 22 Tests CLIA Waived
Alere LFR124

Features Alere BinaxNOW® Influenza A & B Card 2 is an in vitro immunochromatographic assay for the qualitative detection of influenza A and B nucleoprotein antigens in nasopharyngeal (NP) swab and nasal swab samples Alere BinaxNOW® Influenza A & B Card 2 must be read by the Alere™ Reader The first rapid antigen influenza test to achieve 510(k) clearance as a Class II assay under the new FDA Reclassification performance requirements

Manufacturer # LFR124 Brand BinaxNOW® Manufacturer Abbott Rapid Dx North America LLC Country of Origin Japan Application Point-of-Care Analyzer Kit CLIA Classification CLIA Waived Contents 1 Alere™ Reader, Barcode Scanner, Alere Binaxnow® Tray Pack, Calibration Check Card Pack, Alere™ USB Drive Dimensions 125 X 160 X 195 mm For Use With For Alere™ Reader Number of Tests 22 Tests Power Source 100 to 240 VAC, 50/60 Hz Readout Type Touch Screen, Printout Sample Type Nasal Swab / Nasopharyngeal Swab Test Name Influenza A + B Test Time to Results 15 Minute Results UNSPSC Code 41115808 User Interface 4-1/3 Inch Touch Screen Weight 3.3 lbs